You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希諾生物AH股大幅高開 吸入用重組新型冠狀病毒疫苗作為加強針在中國被納入緊急使用
格隆匯9月5日丨港股康希諾生物(6185.HK)高開8.9%,報54.45港元,A股康希諾(688185.SH)高開11.51%,報143.68元。該公司昨日發佈公吿,公司研發的吸入用重組新型冠狀病毒疫苗(5型腺病毒載體),經國家衞生健康委提出建議,國家藥品監督管理局組織論證同意作為加強針納入緊急使用。吸入用重組新型冠狀病毒疫苗(5型腺病毒載體)於2021年3月獲得國家藥品監督管理局藥物臨牀試驗批件,適應症為預防新型冠狀病毒感染所致疾病(COVID-19)。公司吸入用重組新型冠狀病毒疫苗(5 型腺病毒載體)獲批緊急使用後,若後續國家相關部門對其採購使用,將對上市公司的業績產生一定的積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account